No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Earnings Preview: AbbVie to Report Financial Results Pre-market on January 31
$AbbVie(ABBV.US)$ is scheduled to release its financial results pre-market on January 31 ET. Earnings PreviewAnalysts estimate $AbbVie(ABBV.US)$ to post revenue of USD14.82B for 2024Q4, up 3.61% YOY;
Why AbbVie Stock Popped While the Market Flopped on Monday
AbbVie Builds Momentum With Immunology Growth, Goldman Remains Positive
Goldman Sachs Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $208
FDA Accepts Teva, Alvotech BLAs for Simponi Biosimilars
Do Options Traders Know Something About AbbVie (ABBV) Stock We Don't?